Retractable Technologies, Inc. (RVP) |
| 0.7139 -0.006 (-0.85%) 09-03 15:43 |
| Open: | 0.7141 |
| High: | 0.729 |
| Low: | 0.7139 |
| Volume: | 5,454 |
| Market Cap: | 21(M) |
| PE Ratio: | -5.95 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.86 |
| Resistance 1: | 0.74 |
| Pivot price: | 0.72 |
| Support 1: | 0.68 |
| Support 2: | 0.65 |
| 52w High: | 1.14 |
| 52w Low: | 0.6 |
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 03 Sep 2026
A proposed bill would offer tax breaks to make more medical supplies in the U.S. - Stock Titan
Fri, 28 Aug 2026
Retractable Technologies Inc. (RVP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sat, 22 Aug 2026
Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y - Eastern Progress
Thu, 20 Aug 2026
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - TradingView
Fri, 14 Aug 2026
Retractable Technologies: Q2 Earnings Snapshot - KING5.com
Fri, 14 Aug 2026
Retractable Technologies Reports $6.4M Equity-Sale Gain in Q2 - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |